The net profits of “Dr. Sulaiman Al Habib Medical Services Group” (4013) grew 14% YoY in Q2 2024 to around SAR 555 million.
Solid Performance
The three months ending in June saw “Sulaiman Al Habib” revenues swell approximately 13.3% YoY, reaching SAR 2.57 billion.
This comes on the back of continued growth across all operational sectors of the group, which owns and operates several hospitals and specialized medical centers in Saudi Arabia, the UAE, and Bahrain.
So what
The group attributes its positive quarterly results to the performance of its hospital and pharmacy sectors.
This was due to an increase in patient inflows at its hospitals, which similarly drove higher pharmaceutical sales.
Some context
Dr. Sulaiman Al Habib achieved a net profit of approximately SAR 1.1 billion in the first half of 2024, which marked a 13.3% YoY increase from the same period last year.
Now what
The company’s Board of Directors has decided to distribute cash dividends totaling SAR 409.5 million for Q2 2024.
This amounts to SAR 1.17 per share, with the dividends set to be paid on August 19.
